Literature DB >> 17100950

Psychological well-being of mothers of youth with fragile X syndrome: syndrome specificity and within-syndrome variability.

P Lewis1, L Abbeduto, M Murphy, E Richmond, N Giles, L Bruno, S Schroeder, J Anderson, G Orsmond.   

Abstract

BACKGROUND: Research on parental well-being has focused largely on Down syndrome and autism; however, fragile X syndrome is likely to pose different challenges for parents compared with these other diagnostic conditions. Moreover, there is considerable variability among youth with fragile X syndrome; for example, 25% to 33% of affected youth meet criteria for a co-morbid diagnosis of autism. It is likely that parents of youth with fragile X syndrome will experience different degrees and patterns of stress, depending on whether their offspring do or do not have a co-morbid diagnosis of autism. In the present study, we compared mothers of three groups of young males on measures of psychological well-being and stress: those with fragile X syndrome and a co-morbid diagnosis of autism; those with fragile X syndrome alone; and those with Down syndrome.
METHOD: The sample consisted of mothers of adolescent and young adult males with fragile X syndrome and co-morbid autism (n=9), fragile X syndrome alone (n=19), and Down syndrome (n=19). We screened all youth for autism using the Autism Behavior Checklist, which was completed by mothers, fathers and teachers, and the youth who scored above the suggested cut-off were evaluated by a licensed psychologist to determine autism status. The three groups of youth did not differ in chronological age (16.4, 15.8 and 16.0 years, respectively) or non-verbal mental age (3.8, 3.9 and 3.8 years, respectively). Several self-report measures were completed by mothers. These measures assessed current mental health status (e.g. the Center for Epidemiological Studies Depression Scale), perceptions of their son's and family's functioning (e.g. the Positive Affect Index, which measures closeness felt by the mother to her son and also reciprocated closeness felt by the son towards the mother, as perceived by the mother), and approach to coping with their son's disability [e.g. the Multidimensional Coping Inventory (COPE), which measures emotion-focused and problem-solving focused coping].
RESULTS: The results suggest that fragile X syndrome creates more challenges to maternal psychological well-being than Down syndrome, and that the combination of fragile X syndrome and autism can be particularly challenging. Differences among groups, however, were manifested mainly as concerns about the affected son and about relationships within the family rather than as lower levels of mental health. Thus, mothers of sons with fragile X syndrome, regardless of the son's autism status, reported more pessimism about the son's future and more conflict within the family than mothers of sons with Down syndrome. Additionally, mothers of sons with fragile X syndrome and co-morbid autism reported lower levels of reciprocated closeness than the other two groups of mothers.
CONCLUSION: We consider possible causes of these maternal differences, the implications for clinical practice, needs for future research, and the importance of understanding child and contextual factors as well as the dynamics leading to these differences.

Entities:  

Mesh:

Year:  2006        PMID: 17100950     DOI: 10.1111/j.1365-2788.2006.00907.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  22 in total

Review 1.  Can we make assumptions about the psychosocial impact of living as a carrier, based on studies assessing the effects of carrier testing?

Authors:  Celine Lewis; Heather Skirton; Ray Jones
Journal:  J Genet Couns       Date:  2010-09-29       Impact factor: 2.537

2.  Maternal well-being and child behavior in families with fragile X syndrome.

Authors:  Claire T Hauser; Sara T Kover; Leonard Abbeduto
Journal:  Res Dev Disabil       Date:  2014-06-29

3.  Friendships and social participation as markers of quality of life of adolescents and adults with fragile X syndrome and autism.

Authors:  Leann Smith DaWalt; Lauren V Usher; Jan S Greenberg; Marsha R Mailick
Journal:  Autism       Date:  2017-12-12

4.  Psychological Well-being in Fathers of Adolescents and Young Adults with Down Syndrome, Fragile X Syndrome, and Autism.

Authors:  Sigan L Hartley; Marsha Mailick Seltzer; Lara Head; Leonard Abbeduto
Journal:  Fam Relat       Date:  2012-03-13

5.  Behaviour problems, maternal internalising symptoms and family relations in families of adolescents and adults with fragile X syndrome.

Authors:  J K Baker; M M Seltzer; J S Greenberg
Journal:  J Intellect Disabil Res       Date:  2012-06-08

6.  Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.

Authors:  Randi Hagerman; Gry Hoem; Paul Hagerman
Journal:  Mol Autism       Date:  2010-09-21       Impact factor: 7.509

7.  Caregiver Burden in Fragile X Families.

Authors:  Ana-Maria Iosif; Andres F Sciolla; Khyati Brahmbhatt; Andreea L Seritan
Journal:  Curr Psychiatry Rev       Date:  2013-02-01

8.  Social support, coping, and positive perceptions as potential protective factors for the well-being of mothers of children with intellectual and developmental disabilities.

Authors:  Elizabeth J Halstead; Gemma M Griffith; Richard P Hastings
Journal:  Int J Dev Disabil       Date:  2017-05-26

9.  Depression and anxiety symptoms among women who carry the FMR1 premutation: impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms.

Authors:  Jessica Ezzell Hunter; Mary Leslie; Gloria Novak; Debra Hamilton; Lisa Shubeck; Krista Charen; Ann Abramowitz; Michael P Epstein; Adriana Lori; Elisabeth Binder; Joseph F Cubells; Stephanie L Sherman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-09       Impact factor: 3.568

Review 10.  Is there evidence for neuropsychological and neurobehavioral phenotypes among adults without FXTAS who carry the FMR1 premutation? A review of current literature.

Authors:  Jessica Ezzell Hunter; Ann Abramowitz; Michele Rusin; Stephanie L Sherman
Journal:  Genet Med       Date:  2009-02       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.